Kyron.bio

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.

GlycoEra

This company develops glycoengineered biologics to degrade disease-causing extracellular proteins for patients with autoimmune disorders and other inflammatory conditions.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Abalone Bio

This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.

LabGenius

This biopharmaceutical company develops therapeutic antibodies using an automated protein engineering platform for pharmaceutical and biotechnology partners.

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Aikium

This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.

Biothrust

This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.